Trinity Biotech Deferred Tax Liabilities

TRIB

The Deferred Tax Liabilities of Trinity Biotech (TRIB) as of Nov 9, 2026 is 4.56 M USD. In the previous year, Deferred Tax Liabilities was 2.30 M USD — a change of 98.30% (higher).

Get this data via API

Financial Data API

Deferred Tax Liabilities

4.56 MUSD

YoY

98.30%

Last updated: Nov 9, 2026

Deferred Tax Liabilities of Trinity Biotech is 2024 4.56 M USD. Deferred Tax Liabilities of Trinity Biotech was 2023 2.30 M USD. It decreases by 98.30% higher compared to the previous year.

The Trinity Biotech Deferred Tax Liabilities history

3 Years
10 Years
25 Years
Max

Deferred Tax Liabilities

The Trinity Biotech Deferred Tax Liabilities history
YEAR	Deferred Tax Liabilities	YoY
2024	4.56 MUSD	+98.30%
2023	2.30 MUSD	-54.53%
2022	5.06 MUSD	+4.12%
2021	4.86 MUSD	-0.96%
2020	4.91 MUSD	-31.29%
2019	7.14 MUSD	-3.93%
2018	7.43 MUSD	-31.40%
2017	10.83 MUSD	-41.01%
2016	18.36 MUSD	-26.02%
2015	24.82 MUSD	+15.77%
2014	21.44 MUSD	—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Docs Get Free API Key

Trinity Biotech Stock analysis

What does Trinity Biotech do? Trinity Biotech Plc develops, manufactures, and markets medical diagnostic products for clinical laboratories and point-of-care segments. The company operates through the Americas and Rest of World segments, offering products classified as POC, emergency medicine, clinical laboratory, and blood bank screening. Its POC brands include Uni-Gold and Recombigen, used for detecting autoimmune, infectious, and sexually transmitted diseases, diabetes, and liver and intestinal disorders. Emergency medicine diagnostics target acute care testing, STAT labs, pre/post-operative units, physician office labs, and central laboratories. The company supplies clinical laboratory market with reagent products and other products through its clinical chemistry business, while its blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections. Trinity Biotech's products serve healthcare providers in clinical and point-of-care settings, with the Americas and Rest of World segments representing key geographic markets for its diagnostic solutions. Trinity Biotech generates revenue from the sale of diagnostic products across multiple segments, including POC testing, emergency medicine diagnostics, clinical chemistry reagents, and blood bank screening. The company's brands, Uni-Gold and Recombigen, are central to its point-of-care offerings, while its clinical chemistry and blood bank screening businesses provide complementary revenue streams in laboratory and blood donation settings. Trinity Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Trinity Biotech stock

What is the Trinity Biotech Deferred Tax Liabilities 2024?

Deferred Tax Liabilities of Trinity Biotech is 4.56 M USD in 2024.

How has Trinity Biotech Deferred Tax Liabilities changed compared to the previous year?

Deferred Tax Liabilities of Trinity Biotech changed from 2.30 M USD to 4.56 M USD, representing a 98.30% change. The value is higher than the previous year.

How has Trinity Biotech Deferred Tax Liabilities developed historically?

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Trinity Biotech since 2006 – with annual values, charts, and detailed analysis.

What is the Trinity Biotech Deferred Tax Liabilities?

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

How does Trinity Biotech Deferred Tax Liabilities affect the stock price?

Deferred Tax Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Trinity Biotech historically and in real time.

Trinity Biotech Deferred Tax Liabilities

The Trinity Biotech Deferred Tax Liabilities history

Trinity Biotech Stock analysis

Frequently Asked Questions about Trinity Biotech stock

What is the Trinity Biotech Deferred Tax Liabilities 2024?

How has Trinity Biotech Deferred Tax Liabilities changed compared to the previous year?

How has Trinity Biotech Deferred Tax Liabilities developed historically?

What is the Trinity Biotech Deferred Tax Liabilities?

How does Trinity Biotech Deferred Tax Liabilities affect the stock price?

Balance Sheet — Trinity Biotech

All Key Metrics — Trinity Biotech

Valuation

Income Statement

Margins

Balance Sheet

Cash Flow

Profitability

Leverage

Growth

Dividend

Workforce

Quality

Other